Psyence BioMed Announces Exercise of Put Option by PsyLabs and Strategic Equity Investment

12 hours ago

NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical…

Frost & Sullivan: Nucleus Security Receives the 2025 Global Vulnerability Management Transformational Innovation Leadership Recognition for Excellence in AI-Powered Vulnerability Management

12 hours ago

Frost & Sullivan recognizes this company for redefining vulnerability management through its AI-powered platform, data-agnostic architecture, and deeply integrated, automated…

Frost & Sullivan Identifies Top 10 Growth Opportunities in Cloud Communications and Collaboration Services for 2026

17 hours ago

AI-driven transformation, security imperatives, and programmable communications reshape the global UCC landscapeLONDON, Feb. 20, 2026 /PRNewswire/ -- Frost & Sullivan…

NYSE Content Update: Starfighters Space Celebrates NYSE American Listing

1 day ago

NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, Feb. 20, 2026 /PRNewswire/ -- The New York…

Chandigarh University Launches 3-Month ‘SANDBOX Residential Program’ During AI Fest 2026; To Boost Startup Ecosystem in North India

1 day ago

'AI Fest-2026': Chandigarh University Launches 'Centre of Excellence in Digital Marketing' With 'Earn While Learn' Model "Commitment Breeds Outcomes, SANDBOX…

Perfios Launches ‘KScan AI’: Empowers BFSI with AI-powered Business Intelligence and Risk Assessment of 30 Million Indian MSMEs

1 day ago

BENGALURU, India, Feb. 20, 2026 /PRNewswire/ -- Perfios.ai, India's leading B2B SaaS TechFin, today announced the launch of KScan AI, an…

Coca-Cola India Brings Back Rimzim Jeera with a New Campaign that Refuses to be Subtle

1 day ago

NEW DELHI, Feb. 20, 2026 /PRNewswire/ -- India rediscovers its love for local flavours, Coca-Cola is bringing back its cult…

PartnerOne Continues Investment in AI with XYPRO Applied AI Technology

1 day ago

RIVERSIDE, Calif., Feb. 19, 2026 /PRNewswire/ -- XYPRO, a PartnerOne company and market leader of security and compliance solutions for…

ADARx Pharmaceuticals to Present Onvuzosiran (ADX-324) Phase 1/2 Clinical Data and Phase 3 Design at the 2026 AAAAI Annual Meeting

1 day ago

SAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a late-stage clinical biotechnology company developing next-generation RNA…

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

1 day ago

Company Announcement COPENHAGEN, Denmark; February 20, 2026 – Genmab A/S (Nasdaq: GMAB) - In accordance with Article 19 of Regulation…